Amplification of FGFR1 occurs for instance, in non small cell lung cancer (NSCLC) [6] and breast cancer [7], while mutations of FGFR3 are found in bladder and cervix carcinoma [8]. Here, FGFR1 is linked to non-small cell lung carcinoma.